Mitigating a Bioactivation Liability with an Azetidine-Based Inhibitor of Diacylglycerol Acyltransferase 2 (DGAT2) En Route to the Discovery of the Clinical Candidate Ervogastat
- Resource Type
- Source
- Chemical Research in Toxicology.
- Subject
General Medicine Toxicology - Language
- ISSN
- 1520-5010
0893-228X